China Resources Pharmaceutical Group Ltd.
3320
株式のランク
#4221
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
株価
$0.5954966
時価総額
$3.74B
変化（1日）
1.09%
変化（1年）
-2.61%
国
HK
取引 China Resources Pharmaceutical Group Ltd. (3320)
カテゴリー
Healthcare
China Resources Pharmaceutical Group Ltd.（3320）の配当履歴
China Resources Pharmaceutical Group Ltd.（証券コード：3320）は合計で11回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：$1.27
配当利回り（TTM）：0.0512
すべての配当の合計（株式分割調整済み）は：$1.27
配当利回り（TTM）：0.0512
2017から2026までのChina Resources Pharmaceutical Group Ltd.（3320）の配当履歴
年間配当支払い
| 年 | 配当（株式分割調整済み） | 変化 |
|---|---|---|
| 2026 (TTM) | $0.0789 | -41.51% |
| 2025 | $0.1349 | -48.21% |
| 2024 | $0.2605 | 62.81% |
| 2023 | $0.16 | 6.67% |
| 2022 | $0.15 | 25.00% |
| 2021 | $0.12 | 9.09% |
| 2020 | $0.11 | -15.38% |
| 2019 | $0.13 | 18.18% |
| 2018 | $0.11 | 22.22% |
| 2017 | $0.09 | 0.00% |
すべての配当支払いの一覧
| 年 | 配当 | 変化 |
|---|---|---|
| 2026 (TTM) | $0.0789 | -41.51% |
| 2025 | $0.1349 | -48.21% |
| 2024 | $0.2605 | 62.81% |
| 2023 | $0.16 | 6.67% |
| 2022 | $0.15 | 25.00% |
| 2021 | $0.12 | 9.09% |
| 2020 | $0.11 | -15.38% |
| 2019 | $0.13 | 18.18% |
| 2018 | $0.11 | 22.22% |
| 2017 | $0.09 | 0.00% |
同業他社や競合企業の配当履歴
| 企業 | 配当支払い回数 | 国 |
|---|---|---|
| 23.00% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 69.00% |
HK
|
